Physician profile
Abigail K Sofian
NPI 1669926820
$1,652.91
in general payments reported to CMS, 2019-2025
15 companies · $15.34 in 2025
The $15.34 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $517 · 2022: $262 · 2023: $473 · 2024: $386 · 2025: $15.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $551.76 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $228.35 | 2021-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $154.00 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.70 | 2021-2022 | |
| Cranial Technologies, INC | $117.02 | 2021-2024 | Doc Band |
| Seqirus USA INC | $86.20 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Merck Sharp & Dohme LLC | $84.28 | 2021-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $62.16 | 2021 | |
| Glaxosmithkline, LLC. | $55.17 | 2021-2022 | |
| Corium, LLC | $43.45 | 2021 | |
| Sobi, INC | $29.31 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $27.26 | 2024 | |
| Phadia US INC. | $23.60 | 2021 | |
| Ironwood Pharmaceuticals, INC | $18.44 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $18.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abigail Sofian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.